Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

UPDATE 1-AstraZeneca, Oxford Biomedica expand COVID-19 vaccine supply tie-up

Tue, 1st Sep 2020 07:54

(Adds details on supply agreement, background)

Sept 1 (Reuters) - AstraZeneca has expanded its
previous agreement with Oxford Biomedica to mass-produce
the British drugmaker's COVID-19 vaccine candidate, as it looks
to scale-up supply ahead of a possible fast-track approval from
the United States.

Gene and cell therapy firm Oxford Biomedica said on Tuesday
AstraZeneca would give it $15 million upfront to reserve
manufacturing capacity at its plant and that it could get an
additional $35 million plus other costs until the end of 2021
under the new 18-month deal.

AstraZeneca's vaccine hopeful for the novel coronavirus,
AZD1222, already among the leading candidates in the global race
for successful vaccine, moved to late stage trials in the United
States this week as the company targets 3 billion doses of the
vaccine.

Oxford Biomedica was among AstraZeneca's initial partners
when they teamed up in May to produce the vaccine and Tuesday's
deal could be further expanded by another year and a half into
2022 and 2023, Oxford said.

(Reporting by Pushkala Aripaka in Bengaluru; editing by Patrick
Graham)

Related Shares

More News

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

4 May 21 15:50

AstraZeneca's Forxiga gets US approval for chronic kidney disease

(Sharecast News) - AstraZeneca said on Tuesday that Farxiga has been approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes.

4 May 21 07:23

AstraZeneca hails progress on chronic kidney disease with US approval

AstraZeneca hails progress on chronic kidney disease with US approval

3 May 21 07:58

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

30 Apr 21 17:01

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.